OPTOVERA is a workplace safety solution that uses patented technology to detect impairment risk on-the-job due to fatigue, medications, drugs like marijuana and opioids, alcohol, and any impairing neurological condition. The system analyzes users’ pupillary responses to a light stimulus using a testing device that comprises an opaque enclosure containing a smartphone. It's important to note that OPTOVERA does not identify the specific cause of impairment.

OPTOVERA technology uses a testing device, comprising of an opaque enclosure containing a smartphone, to analyze pupillary responses. This assessment, known as Pupillometry, is also utilized in critical care, medical research, and various clinical settings to detect neurological conditions resulting from various factors like injuries, illnesses, drugs, or medications.

The OPTOVERA solution consists of a cloud-based platform and testing devices comprising a Plastic Enclosure containing a preconfigured and locked smartphone. OPTOVERA provides the complete testing device.

OPTOVERA is a self-test. Users simply position the testing device over their eyes and listen to spoken instruction.

The self-test takes just one minute, and the results are displayed on the device screen and sent to the cloud-based platform, where they can be monitored and analyzed.

It is recommended that the individuals taking the test stand with their backs facing a dark area, such as a wall.

Only authorized personnel can access the individual test results of all enrolled users through the cloud-based dashboard.

Yes, the OPTOVERA technology is patented. It is protected by US Patent numbers 9,888,845 and 10,070,787.

Drug testing is a process that aims to detect the presence of drugs in a person's system. It is usually done by analyzing a sample of urine, blood, saliva, or hair.

Impairment risk testing is a process that aims to assess a person's ability to perform their job safely and effectively. It focuses on measuring a person's cognitive and physical abilities, reaction times, and decision-making skills.

Fatigue, sleep deprivation, illness, and certain medical conditions can all cause impairment.

Drug testing aims to detect the presence of drugs in a person's system, while impairment risk testing aims to estimate a person's actual level of impairment due to drugs or other factors.

Impairment risk testing is important because it can help to predict whether a person is able to safely and effectively perform their job duties to prevent accidents and injuries in the workplace.

Impairment testing is generally considered to be a more effective method for assessing a person's ability to perform their job duties safely and effectively, as it focuses on actual impairment rather than just the presence of drugs in a person's system.

The duration of a high-risk of impairment condition is variable. If a person is affected by fatigue, medication, or any drug, after a certain period of time the effects always wear off. However, it can be of very long duration like in the case of trauma or illness.

The Optovera/Sobereye technology does not determine the cause of alterations in pupillary light reflex (PLR) and, as such, should not be used as the sole basis for disciplinary actions. Additionally, it is not intended to be used as evidence in a court of law. The primary purpose of this technology is to help workers recognize conditions that may impact their ability to work safely and to foster a culture of prevention and wellness in the workplace.

No, the company cannot be held liable if a significant event occurs after an employee passes the test. Similar to other technologies designed to detect possible impairment (e.g., breathalyzers), passing the test does not guarantee safety. The test results are not a substitute for established safety protocols. Employees must continue to follow standard safety procedures and guidelines regardless of the test outcome.

OPTOVERA measures alterations of the Pupillary Light Reflex (PLR), which is an involuntary reflex controlled by the Autonomic Nervous System. PLR alteration analysis is a proven and accepted method to reveal neurological anomalies.

The Pupillary Light Reflex (PLR) is an involuntary reflex that controls the size of the eye’s pupil in response to changing light intensity. Pupil constriction and dilation are controlled by the Autonomic Nervous System which regulates bodily functions like heart rate, digestion, respiratory rate, and pupillary response without conscious control.

Pupillary analysis is a valuable tool in medical and scientific fields. It assesses an individual's Pupillary Light Reflex (PLR) response, which serves as a non-invasive indicator of central nervous system functionality. This analysis is conducted using a specialized instrument called a pupillometer, which measures parameters such as pupillary size, symmetry, and reactivity. Expensive, medical grade pupillometers find applications in various fields, including anesthesiology, drug addiction studies, endocrinology, psychiatry, refractive surgery, and sleep disorder research.

Fitness-for-Duty means that a person is physically and mentally able to do their job safely, without risking their own health, their co-workers' safety, company property, or the safety of the public. The pupillary light reflex, which is how our pupils react to light, can be affected by drugs, lack of sleep, and certain neurological conditions that may impair someone's ability to work properly. Pupillary analysis is an effective non-invasive methodology to predict the risk of impairment in Fitness-for-Duty applications.

SOBEREYE measures changes in the Pupillary Light Reflex (PLR), an involuntary reflex that alters the size of the eye's pupil in response to changing light intensity. Each measurement is compared against, a previously acquired, individual’s baseline to detect alterations in pupillary response. The results are specific to each person and therefore extremely accurate. SOBEREYE has been engineered to provide a false positive rate of less than 0.1%. The innovative approach delivers the most convenient and effective solution to predict impairment risk on-the-job, in real-time with a one-minute self-test.

The OPTOVERA system constantly updates the baseline automatically as people continue to test and follows people's slow changes over months and years.

Yes, the OPTOVERA testing device is a pupillometer and is an FDA Class 1, 510(K) exempt device that accurately measures the Pupillary Light Reflex (PLR) of the users. The FDA registration number of the SOBEREYE pupillometer is 10085365

The company has adopted a Data Protection Organizational Model that guarantees the Company's compliance with all legislations regarding personal data (GDPR, HIPAA, LGPD, etc.)

No, our company does not require any personal data of the monitored individuals. Only the customer has control over the identification codes used to create and monitor profiles. As a result, our company cannot identify individual data subjects and does not retain any "personal" data as defined by current legislations.

Our company has implemented technical and organizational measures to ensure the security of processed information. A Data Protection Officer constantly monitors potential impacts on the rights and freedoms of data subjects.

Yes, we can support clients and their Data Protection Officers in performing the required Impact Assessment according to Article 35 of the GDPR, specifically in the description of security measures and data lifecycle.

Our company ISMS comprises people, processes, and technologies that adopt a risk-based approach when implementing security controls, privacy management, and continuity. These elements are essential in supporting business objectives.

Yes, our ISMS is ISO 27001 certified with certification number 3913725.